An adapted enhanced social prescribing intervention vs. usual care in the treatment of loneliness in cancer survivors: Study protocol for a feasibility pilot randomized controlled trial
Brooke Ike, Allison Cole, Brennan Keiser, Alison Tu, Madison Holcroft, Sebastian Tong · 2026
Read An adapted enhanced social prescribing intervention vs. usual care in the treatment of loneliness in cancer survivors: Study protocol for a feasibility pilot randomized controlled trial by Brooke Ike, Allison Cole, Brennan Keiser, Alison Tu, Madison Holcroft, Sebastian Tong (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0350956.txt.
Description
Brooke Ike leads a team of six publishing the plan for a pilot trial of social prescribing against loneliness in cancer survivors, in PLOS ONE in 2026. Social prescribing, a British model, connects patients to community activities and support through a link worker rather than a prescription pad. The team adapted a proven version for survivors using a structured adaptation process, then designed a feasibility trial across two primary care practices serving rural patients in the American Northwest.
Thirty-six survivors who screen positive for loneliness will be assigned by chance to the enhanced program or to usual care with a brochure. The pilot's true endpoints are feasibility questions: can the practices recruit, will survivors accept the offer, and does the program run as designed? A full trial follows only if those answers are yes. The protocol matters because loneliness after cancer is common, harmful, and untouched by oncology's usual tools.
Catalog record
| CREATOR | Brooke Ike, Allison Cole, Brennan Keiser, Alison Tu, Madison Holcroft, Sebastian Tong |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40587 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |